Hiroshi Koga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Koga has a total of 378 co-authors. Here are the top co-authors by number of shared publications:
- Norito Ishii
Department of Dermatology Kurume University School of Medicine Fukuoka Japan
35 shared publications Takekuni Nakama
Department of Dermatology School of Medicine, Kurume University Kurume Japan
26 shared publicationsNorito Ishii
Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan
18 shared publications- Takashi Hashimoto
Department of Dermatology Graduate School of Medicine, Osaka Metropolitan University Osaka Japan
14 shared publications - Kwesi Teye
Kurume University Institute of Cutaneous Cell Biology Fukuoka Japan
13 shared publications - Takahiro Hamada
Department of Dermatology, Kurume University School of Medicine, Kurume, Japan
10 shared publications
Latest Publications
- 16 October 2026
- Published by Wiley in The Journal of Dermatology
Recognizing Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome Through Its Cutaneous Manifestations: Distinction From Werner Syndrome
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL) is an extremely rare autosomal dominant progeroid disorder caused by pathogenic variants in POLD1 . Because MDPL shares many clinical features with Werner syndrome (WS), distinguishing between the two disorders can be challenging. We report a Japanese man with genetically confirmed MDPL caused by the recurrent POLD1 p.Ser605del variant, highlighting its distinctive cutaneous manifestations. The patient exhibited mandibular hypoplasia, limb‐predominant lipodystrophy, skin atrophy, painful plantar clavi and calluses, and later developed prominent telangiectasias. Radiographs at the initial presentation revealed multiple extraosseous calcifications in the lower leg, followed by the development of a refractory skin ulcer over the same calcified region. Computed tomography confirmed calcifications within the subcutaneous tissue and skeletal muscle. To our knowledge, soft‐tissue calcification and refractory skin ulceration have not previously been reported in MDPL. Although MDPL shares substantial clinical overlap with WS, it can be distinguished by its earlier onset, preserved scalp hair, prominent telangiectasias, sensorineural hearing loss, an absence of cataracts, and a lack of a recognized predisposition to malignancy. This case expands the cutaneous spectrum of MDPL and emphasizes the dermatological clues that facilitate its differentiation from WS.
- 16 October 2026
- Published by Wiley in The Journal of Dermatology
Recognizing Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome Through Its Cutaneous Manifestations: Distinction From Werner Syndrome
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL) is an extremely rare autosomal dominant progeroid disorder caused by pathogenic variants in POLD1 . Because MDPL shares many clinical features with Werner syndrome (WS), distinguishing between the two disorders can be challenging. We report a Japanese man with genetically confirmed MDPL caused by the recurrent POLD1 p.Ser605del variant, highlighting its distinctive cutaneous manifestations. The patient exhibited mandibular hypoplasia, limb‐predominant lipodystrophy, skin atrophy, painful plantar clavi and calluses, and later developed prominent telangiectasias. Radiographs at the initial presentation revealed multiple extraosseous calcifications in the lower leg, followed by the development of a refractory skin ulcer over the same calcified region. Computed tomography confirmed calcifications within the subcutaneous tissue and skeletal muscle. To our knowledge, soft‐tissue calcification and refractory skin ulceration have not previously been reported in MDPL. Although MDPL shares substantial clinical overlap with WS, it can be distinguished by its earlier onset, preserved scalp hair, prominent telangiectasias, sensorineural hearing loss, an absence of cataracts, and a lack of a recognized predisposition to malignancy. This case expands the cutaneous spectrum of MDPL and emphasizes the dermatological clues that facilitate its differentiation from WS.
- Open Access
- 18 September 2026
- Published by Wiley in The Journal of Dermatology
Clinical and Patient‐Reported Factors Associated With Impaired Quality of Life in Japanese Patients With Vitiligo: A Multicenter Questionnaire Study Using VitiQoL
Vitiligo can cause a substantial psychosocial burden. However, the clinical and patient‐reported features associated with impaired disease‐specific quality of life (QoL) in Japanese patients remain incompletely characterized. We conducted a multicenter, cross‐sectional questionnaire study to examine the associations between the Vitiligo‐specific Quality‐of‐Life (VitiQoL) instrument and clinical variables reported by patients and physicians. A total of 255 questionnaires were collected, and 227 patients with complete VitiQoL data were included in the main analysis. The mean VitiQoL total score was 40.6 ± 22.4. Higher VitiQoL scores were associated with female sex, exposed‐site involvement, and border hyperpigmentation, with scores increasing progressively with the number of involved exposed regions. VitiQoL scores showed a trend toward an inverse correlation with age. Lesion‐associated symptoms were also associated with higher VitiQoL scores, whereas non‐lesional skin symptoms were not. Lesion‐associated symptoms were associated with physician‐rated disease severity. Treatment response assessed by either patients or physicians was not associated with VitiQoL scores. In multivariable analysis, female sex, younger age, a greater number of exposed regions, and border hyperpigmentation were independently associated with higher VitiQoL scores, whereas physician‐rated disease severity and lesion‐associated symptoms were not. These findings highlight the multifactorial nature of QoL impairment in vitiligo and the importance of incorporating both clinical and patient‐reported features into the assessment of QoL beyond repigmentation‐based treatment response.
- 18 September 2026
- Published by Wiley in The Journal of Dermatology
Open AccessClinical and Patient‐Reported Factors Associated With Impaired Quality of Life in Japanese Patients With Vitiligo: A Multicenter Questionnaire Study Using VitiQoL
Vitiligo can cause a substantial psychosocial burden. However, the clinical and patient‐reported features associated with impaired disease‐specific quality of life (QoL) in Japanese patients remain incompletely characterized. We conducted a multicenter, cross‐sectional questionnaire study to examine the associations between the Vitiligo‐specific Quality‐of‐Life (VitiQoL) instrument and clinical variables reported by patients and physicians. A total of 255 questionnaires were collected, and 227 patients with complete VitiQoL data were included in the main analysis. The mean VitiQoL total score was 40.6 ± 22.4. Higher VitiQoL scores were associated with female sex, exposed‐site involvement, and border hyperpigmentation, with scores increasing progressively with the number of involved exposed regions. VitiQoL scores showed a trend toward an inverse correlation with age. Lesion‐associated symptoms were also associated with higher VitiQoL scores, whereas non‐lesional skin symptoms were not. Lesion‐associated symptoms were associated with physician‐rated disease severity. Treatment response assessed by either patients or physicians was not associated with VitiQoL scores. In multivariable analysis, female sex, younger age, a greater number of exposed regions, and border hyperpigmentation were independently associated with higher VitiQoL scores, whereas physician‐rated disease severity and lesion‐associated symptoms were not. These findings highlight the multifactorial nature of QoL impairment in vitiligo and the importance of incorporating both clinical and patient‐reported features into the assessment of QoL beyond repigmentation‐based treatment response.
- Open Access
- 10 June 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors
- 10 June 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Open AccessBullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors
- 21 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7) , e615-e616
A Case of Hereditary Angioedema Types I/ II That Successfully Achieved Pregnancy and Delivery After Infertility Treatment
- 21 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7) , e615-e616
A Case of Hereditary Angioedema Types I/ II That Successfully Achieved Pregnancy and Delivery After Infertility Treatment
- 19 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7)
Anti–Laminin‐332 Subepidermal Autoimmune Blistering Disease With Extensive Cutaneous Involvement: A Case Report
- 19 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7)
Anti–Laminin‐332 Subepidermal Autoimmune Blistering Disease With Extensive Cutaneous Involvement: A Case Report
- 7 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (6)
A Case of IgM Pemphigoid Suggesting Possible Transition to IgG Mucous Membrane Pemphigoid
- 7 April 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (6)
A Case of IgM Pemphigoid Suggesting Possible Transition to IgG Mucous Membrane Pemphigoid
- Open Access
- 27 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1163-1165
Comparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study
This multicentre study compares four immunoassays for detecting antilaminin 332 IgG in mucous membrane pemphigoid. The keratinocyte footprint assay showed the highest diagnostic accuracy, while the laminin 332 Biochip® provided excellent specificity as a standardized and widely accessible diagnostic option.
- 27 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1163-1165
Open AccessComparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study
This multicentre study compares four immunoassays for detecting antilaminin 332 IgG in mucous membrane pemphigoid. The keratinocyte footprint assay showed the highest diagnostic accuracy, while the laminin 332 Biochip® provided excellent specificity as a standardized and widely accessible diagnostic option.
- Open Access
- 22 December 2025
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105
Paraneoplastic Pemphigus Mimicking Pemphigus Herpetiformis – Overlap of Two Diseases
- 22 December 2025
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105
Open AccessParaneoplastic Pemphigus Mimicking Pemphigus Herpetiformis – Overlap of Two Diseases
- 24 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (1)
Lichenoid Drug Eruption due to Telmisartan–Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report
- 24 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (1)
Lichenoid Drug Eruption due to Telmisartan–Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report